A novel multiplex RPA/CRISPR-Cas12a integrated biosensor for on-site detection of high-risk HPV genotypes
Analytica Chimica Acta · 2026
DOI: 10.1016/j.aca.2025.344830 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2026. Verfasst von Yuying Bao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The Affiliated Zhangjiagang Hospital of Soochow University, Laboratory of Molecular Diagnostics, Suzhou Medical College of So…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Biosensing Techniques, Nucleic Acid Amplification Techniques, Papillomaviridae. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Program of Suzhou, Priority Academic Program Development of Jiangsu Higher Education Institutions.
Abstract (Originalsprache)
Accurate genotyping of high-risk human papillomavirus (HR-HPV) at the point of care is critical for global cervical cancer elimination, but its application remains limited by the need for complex equipment and specialized procedures, particularly in resource-limited regions. Here, we develop H-MRC12a-an integrated platform based on degenerate primers and type-specific crRNAs that combines multiplex recombinase polymerase amplification (RPA) with CRISPR-Cas12a trans-cleavage activity-for ultrasensitive detection of eight key HR-HPV genotypes (16, 18, 31, 33, 52, 53, 58, 66). By introducing a degenerate primer strategy coupled with type-specific crRNAs, the system overcomes interference from primer dimer formation and achieves single-copy sensitivity within 50 min under isothermal conditions (37 °C). Clinical validation demonstrated 100 % concordance with qPCR and identified three additional low viral-load positives (Ct > 35) that were missed by conventional methods. Crucially, the platform enables visual readout under UV light and eliminates the need for specialized instruments. This 'broad-spectrum capture and precision typing' paradigm establishes a versatile framework for multiplexed pathogen detection, advancing accessible molecular diagnostics for global health equity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The Affiliated Zhangjiagang Hospital of Soochow University, Laboratory of Molecular Diagnostics, Suzhou Medical College of Soochow University, Suzhou, 215123, Jiangsu, People's Republic of China.
- Suzhou Food Inspection and Testing Center, Suzhou, 215100, Jiangsu, People's Republic of China.
- Suzhou Medical College of Soochow University, Suzhou, 215000, Jiangsu, People's Republic of China.
- Jiangsu Provincial Medical Key Laboratory of Pathogenic Microbiology in Emerging Major Infectious Diseases, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People's Republic of China.
- Suzhou Center for Disease Control and Prevention, Suzhou, 215003, Jiangsu, People's Republic of China.
- Dushu Lake Hospital, Affiliated to Soochow University, Suzhou, 215004, Jiangsu, People's Republic of China.
Förderung
- Science and Technology Program of Suzhou
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Bao, Y., Ding, W., Zhang, L., Wang, W., Liu, J., Qu, Y., Zhu, L., Zhang, K., Zhong, G., Han, R., Shen, Q., Wang, B., Gu, X., Cao, Y., & Sun, W. (2026). A novel multiplex RPA/CRISPR-Cas12a integrated biosensor for on-site detection of high-risk HPV genotypes. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2025.344830
Vancouver
Bao Y, Ding W, Zhang L, Wang W, Liu J, Qu Y, et al. A novel multiplex RPA/CRISPR-Cas12a integrated biosensor for on-site detection of high-risk HPV genotypes. Analytica Chimica Acta. 2026. doi:10.1016/j.aca.2025.344830
BibTeX
@article{Bao2026,
author = {Bao, Yuying and Ding, Wei and Zhang, Ling and Wang, Wei and Liu, Jia and Qu, Yiting and Zhu, Liguo and Zhang, Kairui and Zhong, Guanxi and Han, Rong and Shen, Qiang and Wang, Bo and Gu, Xinxian and Cao, Ying and Sun, Wanping},
title = {A novel multiplex RPA/CRISPR-Cas12a integrated biosensor for on-site detection of high-risk HPV genotypes},
journal = {Analytica Chimica Acta},
year = {2026},
doi = {10.1016/j.aca.2025.344830}
}
EUVIMED